Tick Paralysis of Animals in Australia

Reference work entry
Part of the Toxinology book series (TOXI)

Abstract

This review encompasses all aspects of tick paralysis relevant to animals in Australia. Tick paralysis is a major animal health problem along the east coast of Australia. Each year an estimated 10,000 dogs and cats are presented to veterinarians for treatment. Many other animal species have been documented to be affected with tick paralysis including horses, cattle, sheep, bats, and other native animals. Ixodes holocyclus and, to a lesser extent in southern Australia, Ixodes cornuatus are the causative tick species. Tick attachment to the host is usually followed by a latent period of 3–6 days during which time the tick engorges and salivary glands enlarge producing a neurotoxin. Paralysis signs are generally caused by the engorgement of one tick but less commonly multiple ticks can be found and occasionally no tick is found. Typical early clinical signs include hind limb ataxia which generally progresses to quadriplegia and death from respiratory failure. Atypical cases may present without generalized paralysis but with only facial paralysis, anisocoria, or gastrointestinal signs such as vomiting and regurgitation may occur making diagnosis difficult. Unexplained actions of the tick toxin include cardiac effects which may contribute to pulmonary edema and ultimately respiratory compromise. The historically elusive molecular nature of the salivary gland secreted 5 kD protein neurotoxin has recently been described and the gene sequence determined. The principle therapeutic agent used in the treatment of affected animals is hyperimmune canine serum. Supportive care of severely affected animals appears important to improve survival outcomes. Response to treatment of early mildly paralyzed animals is good with over 90% of treated reported animals surviving. Animals presenting with severe respiratory compromise and quadriplegia have a poor survival prognosis despite intensive treatment. A range of preventative acaricides are currently available including new generation long-acting oral medications, topical liquids, and washes.

Keywords

Tick paralysis Ixodes holocyclus Animal Antivenom Veterinary 

Abbreviations

CSIRO

Commonwealth Scientific and Industrial Research Organisation

g

Gram

HT-1

Holocyclotoxin 1

IgG

Immunoglobulin G

IgM

Immunoglobulin M

im

Intramuscular

ip

Intraperitoneal

iv

Intravenous

kD

Kilodalton

kg

Kilogram

LD50

Lethal dose 50%

mg

Milligram

mL

Milliliter

NSW

New South Wales

Qld

Queensland

References

  1. Anastopoulos P, Thurn MJ, Broady KW. Anticoagulant in the tick Ixodes holocyclus. Aust Vet J. 1991;68:366–7.CrossRefPubMedGoogle Scholar
  2. Askenase PW, Bagnall BG, Worms MJ. Cutaneous basophil-associated resistance to ectoparasites (ticks). I. Transfer with immune serum or immune cells. Immunology. 1982;45:501–11.PubMedPubMedCentralGoogle Scholar
  3. Atwell RB, Campbell FE. Reactions to tick antitoxin serum and the role of atropine in treatment of dogs and cats with tick paralysis caused by Ixodes holocyclus: a pilot survey. Aust Vet J. 2001;79:394–7.CrossRefPubMedGoogle Scholar
  4. Atwell R, Campbell F, Court E. The attachment sites of the paralysis tick (Ixodes holocyclus) on dogs. Aust Vet Pract. 2000;30:68–72.Google Scholar
  5. Atwell RB, Campbell FE, Evans EA. Prospective survey of tick paralysis in dogs. Aust Vet J. 2001;79:412–8.CrossRefPubMedGoogle Scholar
  6. Barker SC, Walker AR. Ticks of Australia. The species that infest domestic animals and humans. Zootaxa. 2014;3816:1–144.CrossRefGoogle Scholar
  7. Barker SC, Walker AR, Campelo D. A list of the 70 species of Australian ticks; diagnostic guides to and species accounts of Ixodes holocyclus (paralysis tick), Ixodes cornuatus (southern paralysis tick) and Rhipicephalus australis (Australian cattle tick); and consideration of the place of Australia in the evolution of ticks with comments on four controversial ideas. Int J Parasitol. 2014;44:941–53.CrossRefPubMedGoogle Scholar
  8. Beveridge I. Ixodes holocyclus in the Melbourne metropolitan area. Aust Vet J. 1991;68:214.CrossRefPubMedGoogle Scholar
  9. Beveridge I, Coleman G. Tick paralysis of dogs in Victoria due to Ixodes cornuatus. Aust Vet J. 2004;82:642–3.CrossRefPubMedGoogle Scholar
  10. Bootes B. A fatal paralysis in foals from Ixodes holocyclus Neumann infestation. Aust Vet J. 1962;38:68–9.CrossRefGoogle Scholar
  11. Campbell F, Atwell R. Megaoesophagus in dogs with tick paralysis (Ixodes holocyclus). Aust Vet Pract. 2001;31:75–9.Google Scholar
  12. Campbell FE, Atwell RB. Long QT syndrome in dogs with tick toxicity (Ixodes holocyclus). Aust Vet J. 2002;80:611–6.CrossRefPubMedGoogle Scholar
  13. Campbell F, Atwell R. Heart failure in dogs with tick paralysis caused by the Australian paralysis tick, Ixodes holocyclus. Int J Appl Res Vet Med. 2003;1:148–62.Google Scholar
  14. Campbell FE, Atwell RB, Smart L. Effects of the paralysis tick, Ixodes holocyclus, on the electrocardiogram of the spectacled flying fox, Pteropus conspicillatus. Aust Vet J. 2003;81:328–31.CrossRefPubMedGoogle Scholar
  15. Campbell F, Atwell R, Fenning A, Hoey A, Brown L. Cardiovascular effects of the toxin(s) of the Australian paralysis tick, Ixodes holocyclus, in the rat. Toxicon. 2004;43:743–50.CrossRefPubMedGoogle Scholar
  16. Cooper B, Spence I. Temperature-dependent inhibition of evoked acetycholine release in tick paralysis. Nature. 1976;263:693–5.CrossRefPubMedGoogle Scholar
  17. Cooper B, Cooper H, Ilkiw J, Kelly J. Tick paralysis. Proceedings No. 30 – Neurology. Sydney Postgraduate Foundation; 1976. p. 57–61.Google Scholar
  18. Davey M, Ratcliffe R, Titchen D. Aspects of the symptomatology and intoxication produced by Ixodes holocyclus. In: Proceedings of the Sydney Allergen Group. vol. 6. 1988; p. 49. 1988.Google Scholar
  19. Dodd S. Tick paralysis. J Comp Pathol Ther. 1921;34:309–23.CrossRefGoogle Scholar
  20. Doube B. Cattle and the paralysis tick Ixodes holocyclus. Aust Vet J. 1975;51:511–5.CrossRefPubMedGoogle Scholar
  21. Doube BM, Kemp DH. Paralysis of cattle by ixodes holocyclus Neumann. Aust J Agric Res. 1975;26:635.CrossRefGoogle Scholar
  22. Doube B, Kemp DH, Bird P. Paralysis of calves by the tick, Ixodes holocyclus. Aust Vet J. 1977;53:39.CrossRefGoogle Scholar
  23. Doube BM, Goodger BV, Stone BF, Nolan J. Toxic secretions in cuticular washings from the Australian paralysis tick, Ixodes holocyclus. Toxicon. 1995;33:304.CrossRefGoogle Scholar
  24. Fearnley A. The importance of body temperature in the treatment of tick paralysis. Aust Vet Pract. 2002;32:137–8.Google Scholar
  25. Fisara P, Webster M. A randomized controlled trial of the efficacy of orally administered fluralaner (Bravecto) against induced Ixodes holocyclus (Australian paralysis tick) infestations on dogs. Parasit Vectors. 2015;8:257.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Fitzgerald M. Ixodes holocyclus poisoning. Clinical Toxicology, Sydney Postgraduate Foundation; 1998. p. 203–20.Google Scholar
  27. Fitzgerald M. Tick toxicity in a cat caused by the larval stage of Ixodes holocyclus. Aust Vet Pract. 2007;37:32.Google Scholar
  28. Goodrich BS, Murray MD. Factors influencing the toxicity of salivary gland extracts of Ixodes holocyclus Neumann. Int J Parasitol. 1978;8:313–20.CrossRefPubMedGoogle Scholar
  29. Hall-Mendelin S, Craig SB, Hall RA, O’Donoghue P, Atwell RB, Tulsiani SM, Graham GC. Tick paralysis in Australia caused by Ixodes holocyclus Neumann. Ann Trop Med Parasitol. 2011a;105:95–106.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Hall-Mendelin S, O’Donoghue P, Atwell RB, Lee R, Hall RA. An ELISA to detect serum antibodies to the salivary gland toxin of Ixodes holocyclus Neumann in dogs and rodents. J Parasitol Res. 2011b;2011:283416.CrossRefPubMedPubMedCentralGoogle Scholar
  31. Hindmarsh W, Pursell R. Tick paralysis of dogs. Mortality after serum treatment. Aust Vet J. 1935;11:229–34.CrossRefGoogle Scholar
  32. Holland CT. Asymmetrical focal neurological deficits in dogs and cats with naturally occurring tick paralysis (Ixodes holocyclus): 27 cases (1999–2006). Aust Vet J. 2008;86:377–84.CrossRefPubMedGoogle Scholar
  33. Hutton JB. Tick (Ixodes holocyclus) paralysis in an imported dog. N Z Vet J. 1974;22:173.CrossRefPubMedGoogle Scholar
  34. Ilkiw JE. Tick paralysis in Australia. In: Kirk RW, editor. Current veterinary therapy IX. Philadelphia: Lea and Febiger; 1983.Google Scholar
  35. Ilkiw JE, Turner DM. Infestation in the dog by the paralysis tick, Ixodes holocyclus. 5. Treatment. Aust Vet J. 1988;65:236–8.CrossRefPubMedGoogle Scholar
  36. Ilkiw JE, Turner DM, Howlett CR. Infestation in the dog by the paralysis tick Ixodes holocyclus. 1. Clinical and histological findings. Aust Vet J. 1987;64:137–9.CrossRefPubMedGoogle Scholar
  37. Jackson J, Beveridge I, Chilton NB, Andrews RH. Distributions of the paralysis ticks Ixodes cornuatus and Ixodes holocyclus in south-eastern Australia. Aust Vet J. 2007;85:420–4.CrossRefPubMedGoogle Scholar
  38. Jones D. Tick paralysis. Proceedings No. 149 – Emergency Medicine and Critical Care; Sydney Postgraduate Foundation; 1991. p. 153–65.Google Scholar
  39. Jonsson NN, Rozmanec M. Tick paralysis and hepatic lipidosis in a llama. Aust Vet J. 1997;75:250–3.CrossRefPubMedGoogle Scholar
  40. Kaire G. A method for assay of canine tick anti-serum. Aust Vet J. 1965;41:239–40.CrossRefGoogle Scholar
  41. Kaire GH. Isolation of tick paralysis toxin from Ixodes holocyclus. Toxicon. 1966;4:91–7.CrossRefPubMedGoogle Scholar
  42. Kelers K, Barker S, Song S. Identification of Ixodes holocyclus by DNA sequencing: application for suspected tick envenomation in a dog living outside an enzootic area. Aust Vet Pract. 2012;42:240.Google Scholar
  43. Malik R, Farrow BR. Tick paralysis in North America and Australia. The Veterinary Clinics of North America. Small Anim Pract. 1991;21:157–71.CrossRefGoogle Scholar
  44. Malik R, King J, Allan G. Megaoesophagus associated with tick paralysis in three dogs. Aust Vet Pract. 1988;18:156–9.Google Scholar
  45. Masina S, Broady KW. Tick paralysis: development of a vaccine. Int J Parasitol. 1999;29:535–41.CrossRefPubMedGoogle Scholar
  46. Murray M, Koch J. The engorgement of Ixodes holocyclus Neuman (Acarina: Ixodoidea) on mice. J Aust Entomol Soc. 1969;8:187.CrossRefGoogle Scholar
  47. Nicholson GM, Graudins A, Wilson HI, Little M, Broady KW. Arachnid toxinology in Australia: from clinical toxicology to potential applications. Toxicon. 2006;48:872–98.CrossRefPubMedGoogle Scholar
  48. Oxer D. The preparation of canine anti-tick serum. Aust Vet J. 1948;24:95–6.CrossRefGoogle Scholar
  49. Oxer D, Ricardo C. Notes on the biology, toxicity and breeding of Ixodes holocyclus (Neuman). Aust Vet J. 1942;18:194–9.CrossRefGoogle Scholar
  50. Pearn J. Neuromuscular paralysis caused by tick envenomation. J Neurol Sci. 1977;34:37–42.CrossRefPubMedGoogle Scholar
  51. Riek R. Studies on the reactions of animals to infestation with ticks II. Tick Toxins. Aust J Agric Res. 1957;8:215.CrossRefGoogle Scholar
  52. Ross I. The bionomics of Ixodes holocyclus Neumann, with a redescription of the adult and nymphal stages and a description of the larvae. Parasitology. 1924;16:365.CrossRefGoogle Scholar
  53. Ross I. An experimental study of tick paralysis in Australia. Parasitology. 1926;18:410.CrossRefGoogle Scholar
  54. Ross I. An experimental study of tick paralysis in Australia. Aust Vet J. 1927a;3:71–2.CrossRefGoogle Scholar
  55. Ross I. The treatment of tick paralysis. Aust Vet J. 1927b;3:72–4.CrossRefGoogle Scholar
  56. Ross I. Tick paralysis in the dog caused by nymphs of Ixodes holocyclus. Aust Vet J. 1932;8:102–4.CrossRefGoogle Scholar
  57. Ross I. Tick paralysis in the dog. Period elapsing between attachment of tick and the onset of symptoms. Aust Vet J. 1934;10:182–3.CrossRefGoogle Scholar
  58. Ross I. Tick paralysis: a fatal disease of dogs and other animals in Eastern Australia. J Counc Sci Ind Res. 1935;8:8–13.Google Scholar
  59. Ruppin M, Sullivan S, Condon F, Perkins N, Lee L, Jeffcott LB, Dart AJ. Retrospective study of 103 presumed cases of tick (Ixodes holocyclus) envenomation in the horse. Aust Vet J. 2012;90:175–80.CrossRefPubMedGoogle Scholar
  60. Schull D. Acute side effects attributed to the use of tick antitoxin serum: a review of available descriptions. Aust Vet Pract. 2007;37:98.Google Scholar
  61. Schull DN, Litster AL, Atwell RB. Tick toxicity in cats caused by Ixodes species in Australia: a review of published literature. J Feline Med Surg. 2007;9:487–93.CrossRefPubMedGoogle Scholar
  62. Scott A. Dr Bernard Stone AM, DSc. Aust Soc Parasitol Newsl. 2005;16:4–5.Google Scholar
  63. Sloan C. Mortality in sheep due to Ixodes species. Aust Vet J. 1968;44:527.CrossRefPubMedGoogle Scholar
  64. Stone B. Vaccination of rabbits against the toxin of the Australian paralysis tick Ixodes holocyclus. Toxicon. 1983;21:421–4.CrossRefGoogle Scholar
  65. Stone B. No.3: Tick paralysis: antitoxin and vaccine perspectives, Mailing No. 153, Perspective No. 3, p. 9–12, Apr 1990.Google Scholar
  66. Stone B, Aylward JH. Tick toxicoses and the causal toxins: tick paralysis. In: Gopalakrishnakone P, Tan C, editors. Progress in venom and toxin research. Singapore: Postgraduate Foundation Veterinary Scice; 1987. p. 594.Google Scholar
  67. Stone BF, Neish AL. Tick-paralysis toxoid: an effective immunizing agent against the toxin of Ixodes holocyclus. Aust J Exp Biol Med Sci. 1984;62(Pt 2):189–91.CrossRefPubMedGoogle Scholar
  68. Stone B, Wright IG. Ticks and tick borne diseases. Proceedings of a Symposium held at the 56th Annual Conference of the Australian Veterinary Association, Townsville, Published by the Australian Veterinary Association 1980; p. 75–8.Google Scholar
  69. Stone B, Wright I. Tick toxins and protective immunity. In: Whitehead GB, and Gibson JD, editors. Tick biology and control, South Africa: Grahamstown; 1981. p. 1–5.Google Scholar
  70. Stone B, Doube B, Binnington K. Toxins of the Australian paralysis tick Ixodes holcyclus. Recent Adv Acarol. 1979;1:347.Google Scholar
  71. Stone BF, Cowie MR, Kerr JD, Binnington KC. Improved toxin/antitoxin assays for studies on the Australian paralysis tick Ixodes holocyclus. Aust J Exp Biol Med Sci. 1982;60:309–18.CrossRefPubMedGoogle Scholar
  72. Stone B, Wright I, Neish AL. Natural and artificial immunisation of dogs against tick paralysis induced by the Australian paralysis tick Ixodes holocyclus. Toxicon. 1983;21:417–20.CrossRefGoogle Scholar
  73. Tee SY, Feary DJ. Suspected tick paralysis (Ixodes holocyclus) in a Miniature Horse. Aust Vet J. 2012;90:181–5.CrossRefPubMedGoogle Scholar
  74. Thurn MJ, Gooley A, Broady K. Identification of the neurotoxin from the Australian paralysis tick, Ixodes holocyclus. In: Gopalakrishnakone P, Tan C, editors. Recent advances in toxinology research. Singapore; 1992. p. 243.Google Scholar
  75. Trigg N, Leister E, Whitney J, McAlees T. Outcomes of mechanical ventilation in 302 dogs and cats in Australia (2005–2013). Aust Vet Pract. 2014;44:698–703.Google Scholar
  76. Vink S, Daly NL, Steen N, Craik DJ, Alewood PF. Holocyclotoxin-1, a cystine knot toxin from Ixodes holocyclus. Toxicon. 2014;90:308–17.CrossRefPubMedGoogle Scholar
  77. Webster RA. Tick paralysis 1- pathophysiology, controversies and initial management, continuing veterinary education, Emergency Conference, Proceedings No. 411; 2014a.Google Scholar
  78. Webster, RA. Tick paralysis 2: critical care of patients with tick paralysis, continuing veterinary education. Proceedings No. 411; 2014b. p. 91.Google Scholar
  79. Webster RA, Mackie JT, Haskins SC. Histopathological changes in the lungs from dogs with tick paralysis: 25 cases (2010–2012). Aust Vet J. 2013a;91:306–11.CrossRefPubMedGoogle Scholar
  80. Webster RA, Mills PC, Morton JM. Indications, durations and outcomes of mechanical ventilation in dogs and cats with tick paralysis caused by Ixodes holocyclus: 61 cases (2008–2011). Aust Vet J. 2013b;91:233–9.CrossRefPubMedGoogle Scholar
  81. Westwood MN, Emery DL, Dhand NK. Clinical presentation and treatment of tick paralysis in dogs and cats in Sydney (2001–2010). Aust Vet J. 2013;91:491–8.CrossRefGoogle Scholar
  82. Zucker I, Cornish K. The Bezold-Jarisch Reflex in the conscious dog. Circ Res. 1981;49:940–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Australian Venom Research Unit, Department of Pharmacology and Therapeutics, Faculty of MedicineUniversity of Melbourne, ParkvilleMelbourneAustralia

Personalised recommendations